Dr Harvey Jia Wei Koh is a postdoctoral research fellow and lead of Computational Pharmacoepidemiology within the Pharmacoepidemiology Research Group at Monash University's School of Public Health and Preventive Medicine. His work focuses on developing novel explainable Bayesian machine learning and trajectory mining methods for pharmacoepidemiology. An interdisciplinary researcher with publications in leading journals such as Nature Digital Medicine, Dr Koh leads a translational research programme spanning applied machine learning, health informatics, and artificial intelligence. He holds a joint affiliation with the Faculty of Information Technology, Monash Institute of Pharmaceutical Science (MIPS) and maintains active collaborations with major health services, professional bodies, and national research consortia.

Brayden Gibson is a PhD candidate in Public Health with the Pharmacoepidemiology Research Group at Monash University. His research focuses on improving the detection, evaluation and reporting of drug drug interactions through epidemiological methods, consensus approaches, literature synthesis and data driven modelling. He has previously examined the reliability and validity of drug drug interaction checkers, highlighting variation in how these tools identify, classify and communicate interaction risks. By combining rigorous epidemiological methods with data driven approaches, Brayden’s research goal is to create robust tools and frameworks that improve the detection of harmful drug drug interactions, enable safer prescribing, and support regulatory decision making worldwide.

Nick Buckley (MD FRACP FTAPNA FACMT FAACT FEAPCCT FAHMS) is Professor of Clinical Pharmacology at the University of Sydney, a consultant clinical toxicologist at the NSW Poisons Information Centre and admitting toxicologist at RPA Hospital Sydney, Chair of the Editorial Advisory Board of the Australian Medicines Handbook, Chair of the Australian Therapeutic Guidelines Toxicology and Toxinology writing group, a past President of The Asia Pacific Association of Medical Toxicology, and co-founder of the South Asian Clinical Toxicology Research Collaboration (SACTRC- http://www.sactrc.org). http://sydney.edu.au/medicine/people/academics/profiles/nicholas.buckley.php http://orcid.org/0000-0002-6326-4711

Associate Professor Jenni Ilomaki has expertise in clinical pharmacy, epidemiology and public health. Jenni leads a dynamic and expanding research group focused on analyses of administrative claims data. Jenni and her team collaborate with a range of government and non-government organisations in Australia and internationally. Jenni has published >150 articles in peer-reviewed scientific journals and obtained AUD >$4 million in grant funding. Jenni is the former Chair of the Pharmacoepidemiology Special Interest Group of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). She is Science Lead of Monash Addiction Research Centre and Executive Editor of British Journal of Clinical Pharmacology. Jenni graduated with a Bachelor of Science (Pharmacy) from the University of Kuopio in 1999, and Master of Science (Pharmacy) in 2004. In 2000, Jenni was instrumental in establishing Finland’s first drug information centre KLIK. From 2002-2005 KLIK responded to more than 27,000 inquiries from consumers, pharmacies and hospitals across Finland. In 2006-2007, Jenni was a visiting scholar at the University of Florida Department of Pharmaceutical Outcomes and Policy. Jenni then returned to Finland and undertook a PhD in alcohol epidemiology at the Department of Public Health and Clinical Nutrition at the University of Eastern Finland. During her PhD Jenni published the first application of a marginal structural model in alcohol epidemiology. For this landmark work the Finnish Epidemiological Society named Jenni the Young Epidemiologist of the Year 2011. The Finnish Graduate School of Pharmaceutical Research recognised Jenni’s work by awarding her the Best Thesis in Pharmaceutical Sciences 2010-2011. Jenni was Postdoctoral Research Fellow at the University of South Australia from 2011-2014, during which time she analysed data and prepared reports on behalf of the Australian Government Department of Veterans’ Affairs and NPS MedicineWise.

Edward is a community pharmacist in Australia and PhD student at the University of Sydney with a research interest in pharmacoepidemiology in older people, especially people living with dementia in community settings in Australia. He is particularly interested in the prevalence, risk factors and outcomes of high-risk prescribing in this population. His research is aimed at improving the safety and effectiveness of medication use in people living with dementia.

Patricia Jiefei Yu is a PhD candidate in pharmacy practice at University of Sydney, where her research focuses on optimising medication management and healthcare utilisation in people with dementia.